The short version of HGF mimetic fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-18 and is reviewed periodically as new material appears.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Melanocytes express many proinflammatory cytokines including IL-1, IL-3, IL-6, IL-8, TNF-α, and TGF-β. Like other immune cells, melanocytes secrete these cytokines in response to activation of Pattern Recognition Receptors (PRRs) such as Toll Like Receptor 4 (TLR4) which recognize MAMPs. MAMPs, also known as PAMPs, are microbial associated molecular patterns, small molecular elements such as proteins, carbohydrates, and lipids present on or in a given pathogen. In addition, cytokine production by melanocytes can be triggered by cytokines secreted by other nearby immune cells. Melanocytes are ideally positioned in the epidermis to be sentinels against harmful pathogens. They reside in the stratum basale, the lowest layer of the epidermis, but they use their dendrites to interact with cells in other layers, and to capture pathogens that enter the epidermis. They likely work in concert with both keratinocytes and Langerhans cells, both of which are also actively phagocytic, to contribute to the immune response.
==== Early militant activity ==== As early as 1960, minority rule in Southern Rhodesia was already being challenged by a rising tide of political violence led by black African nationalists such as Joshua Nkomo and Ndabaningi Sithole. A sustained period of civil unrest between 1960 and 1965 further polarised relations between the government and the increasingly militant black nationalists. After their public campaigns were initially suppressed, many black nationalists believed that negotiation was completely incapable of meeting their aspirations. Petrol bombings by politicised radicals became increasingly common, with the Zimbabwe Review observing in 1961, "for the first time home-made petrol bombs were used by freedom fighters in Salisbury against settler establishments." Between January and September 1962, nationalists detonated 33 bombs and were implicated in 28 acts of arson, and 27 acts of sabotage against communications infrastructure. The nationalists also murdered a number of black Rhodesians who were accused of collaboration with the security forces. Nkomo's party, the Zimbabwe African People's Union (ZAPU) announced that year that it had formed a military wing, the Zimbabwe People's Revolutionary Army (ZIPRA) and "the decision to start bringing in arms and ammunition and to send young men away for sabotage training" had already been implemented.
=== Respiration === Cephalopods exchange gases with the seawater by forcing water through their gills, which are attached to the roof of the organism. Water enters the mantle cavity on the outside of the gills, and the entrance of the mantle cavity closes. When the mantle contracts, water is forced through the gills, which lie between the mantle cavity and the funnel. The water's expulsion through the funnel is used to power jet propulsion. If respiration is used concurrently with jet propulsion, large losses in speed or oxygen generation can be expected. The gills, which are much more efficient than those of other mollusks, are attached to the ventral surface of the mantle cavity. There is a trade-off with gill size regarding lifestyle. To achieve fast speeds, gills need to be small – water will be passed through them quickly when energy is needed, compensating for their small size. However, organisms which spend most of their time moving slowly along the bottom do not naturally pass much water through their cavity for locomotion; thus they have larger gills, along with complex systems to ensure that water is constantly washing through their gills, even when the organism is stationary. The water flow is controlled by contractions of the radial and circular mantle cavity muscles. The gills of cephalopods are supported by a skeleton of robust fibrous proteins; the lack of mucopolysaccharides distinguishes this matrix from cartilage. The gills are also thought to be involved in excretion, with NH4+ being swapped with K+ from the seawater.
== Terminology == A child is referred to as the stepdaughter or stepson of their biological or adoptive parent's new spouse, and the spouse is referred to as the stepparent (father or mother) of the child. A stepparent is the spouse of someone's parent, and not their biological parent, stepfather being the male spouse and stepmother the female spouse. A step-grandparent is the step-parent of someone's parent or the parent of one's step-parent, and not someone's biological grandparent, stepgrandfather being the male one, and stepgrandmother the female one. A step-uncle is the spouse of someone's parent's sister (aunt) or brother (uncle) and is not the father of someone's cousin, except when the sibling marries another and never has children (no cousins). The sister's niece/nephew should refer to a new spouse as uncle, not step-uncle. A step-aunt is the spouse of someone's parent's brother (uncle) or sister (aunt) and is not the mother of someone's cousin, except when the sibling marries another and never had children (no cousins). The sister's niece or nephew should refer to the newest spouse as aunt, not step-aunt. Similarly, a stepsibling is the offspring of a stepparent to whom one is not biologically or adoptive related, stepbrother being the male one and stepsister the female one. A stepgrandson is the grandson of someone's spouse who one is not biologically related to. A step-granddaughter is the granddaughter of someone's spouse to whom one is not biologically or adoptive related.
=== Asymptomatic and presymptomatic transmission === On 1 February 2020, the World Health Organization (WHO) indicated that "transmission from asymptomatic cases is likely not a major driver of transmission". One meta-analysis found that 17% of infections are asymptomatic, and asymptomatic individuals were 42% less likely to transmit the virus. However, an epidemiological model of the beginning of the outbreak in China suggested that "pre-symptomatic shedding may be typical among documented infections" and that subclinical infections may have been the source of a majority of infections. That may explain how out of 217 on board a cruise liner that docked at Montevideo, only 24 of 128 who tested positive for viral RNA showed symptoms. Similarly, a study of ninety-four patients hospitalised in January and February 2020 estimated patients began shedding virus two to three days before symptoms appear and that "a substantial proportion of transmission probably occurred before first symptoms in the index case". The authors later published a correction that showed that shedding began earlier than first estimated, four to five days before symptoms appear.
Sources: en.wikipedia.org
== Academic integrity == SCIRP generated controversy in 2010 when it was found that its journals duplicated papers which had already been published elsewhere, without notification of or permission from the original author and of the copyright holder. Several of these publications have subsequently been retracted. Some of the journals had listed academics on their editorial boards without their permission or even knowledge, sometimes in fields very different from their own. In 2012, one of its journals, Advances in Pure Mathematics, accepted a paper written by a parody generator; the paper was not published, but only due to its author's unwillingness to pay the publication fee. The company has also been noted for the many unsolicited bulk emails it sends to academics about its journals. In 2013, the Open Journal of Pediatrics, a SCIRP journal, published a study which concluded that the number of babies born with thyroid problems in the western United States increased by 16 percent in 2011 compared to 2010, after the Fukushima Daiichi nuclear disaster. The study has been criticized for not taking into account the fact that 2010 was a year with an unusually low number of births with thyroid problems. SCIRP refused to print a letter criticizing the study, but offered to publish it as an article for a charge. The company has been included in a list of questionable open access publishers, according to Jeffrey Beall's criteria. Beall states that "This publisher exists for two reasons.
the presence of acid (primarily the secreted HCl) that leads to a low pH in the stomach (a case of negative feedback) somatostatin also inhibits the release of gastrin, along with secretin, GIP (gastroinhibitory peptide), VIP (vasoactive intestinal peptide), glucagon and calcitonin.
LSD's psychedelic properties were discovered 5 years later when Hofmann himself accidentally ingested an unknown quantity of the chemical. The first intentional ingestion of LSD occurred on April 19, 1943, when Hofmann ingested 250 μg of LSD. He said this would be a threshold dose based on the doses of other ergot alkaloids; however, Hofmann found the effects to be much stronger than he anticipated. Information about synthesizing LSD was first published in scientific literature by Hofmann and his colleague, psychiatrist Werner Stoll in 1943; a description of LSD's hallucinogenic effects was later published by Stoll in 1947.
CDMT can be prepared from cyanuric chloride in a mixture of methanol, water and sodium bicarbonate. CDMT directly precipitates from this aqueous reaction mixture, but careful control of base stoichiometry and temperature is required to obtain high selectivity between the mono-, di- and trimethoxy-triazines and prepare CDMT in high yield. DMTMM is prepared in a nucleophilic aromatic substitution between CDMT and NMM.
Sources: en.wikipedia.org
=== Daytime Emmy Awards === Overall 19-time winner: 14-time winner of Daytime Emmy Award for Outstanding Game Show Host, as host of The Price Is Right 4-time winner of Daytime Emmy Award for Outstanding Game Show, as executive producer of The Price Is Right Lifetime Achievement Award, presented at the 1999 Daytime Emmy Awards
Trichrome staining is a histological staining method that uses two or more acid dyes in conjunction with a polyacid. Staining differentiates tissues by tinting them in contrasting colours. It increases the contrast of microscopic features in cells and tissues, which makes them easier to see when viewed through a microscope. The word trichrome means "three colours". The first staining protocol that was described as "trichrome" was Mallory's trichrome stain, which differentially stained erythrocytes to a red colour, muscle tissue to a red colour, and collagen to a blue colour. Some other trichrome staining protocols are the Masson's trichrome stain, Lillie's trichrome, and the Gömöri trichrome stain.
== History == GABA is the principal inhibitory neurotransmitter in mammalian brains. By the early 1970s, it was appreciated that there are two main classes of GABA receptors, GABAA and GABAB and also that baclofen was an agonist of GABAB receptors. Gabapentin was designed, synthesized, and tested in mice by researchers at the pharmaceutical company Goedecke AG in Freiburg, Germany (a subsidiary of Parke-Davis). It was meant to be a structural analog of the neurotransmitter GABA that could more easily cross the blood–brain barrier. It was first synthesized in 1974/75 and described in 1975 by Satzinger and Hartenstein. The first pharmacology findings published were sedating properties and prevention of seizures in mice evoked by the GABA antagonist, thiosemicarbazide. Shortly after, gabapentin was shown in vitro to reduce the release of the neurotransmitter dopamine from slices of rat caudate nucleus (striatum). This study provided evidence that the action of gabapentin, unlike baclofen, did not arise from the GABAB receptor. Initial clinical trials using small numbers of subjects were for treatment of spasticity and migraine but neither study had statistical power to allow conclusions. In 1987, the first positive results with gabapentin were obtained in a clinical trial using three dose groups versus pre-treatment seizure frequency for 75 days, as add-on treatment in patients who still had seizures despite taking other medications. Under the brand name Neurontin, it was first approved in the United Kingdom in May 1993, for the treatment of refractory epilepsy.
Terlipressin, sold under the brand name Terlivaz among others, is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help. Terlipressin is a vasopressin receptor agonist. Terlipressin was approved for medical use in the United States in 2022. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
=== Frozen fish food === Perishable food can be preserved by frozen storage, and is often sold in blister packs or resealable packets. These can contain a variety of ingredients such as bloodworms, Daphnia, or brine shrimp, and are commonly used to feed such fish as Discus which require a high protein diet. Often fed on beef heart fish food within the aquaculture industry, the discus fish are not the only fish which can benefit from a high quality prepared frozen mixture such as beef heart, although by far these are the fish most associated with this particular frozen food.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Liquid chromatography–mass spectrometry is commonly used. It provides molecular mass and purity information. Other methods may include HPLC with ultraviolet detection.